Hemorrhagic fever caused by a novel Bunyavirus in china: Pathogenesis and correlates of fatal outcome

Clinical Infectious Diseases

Volumn 54, Issue 4, 2012, Pages 527-533

  Zhang, Yong Zhen ^a   He, Yong Wen ^b   Dai, Yong An ^c   Xiong, Yanwen ^a   Zheng, Han ^a   Zhou, Dun Jin ^d   Li, Juan ^a   Sun, Qiangzheng ^a   Luo, Xue Lian ^a   Cheng, Yu Li ^a   Qin, Xin Cheng ^a   Tian, Jun Hua ^d   Chen, Xiao Ping ^a   Yu, Bin ^d   Jin, Dong ^a   Guo, Wen Ping ^a   Li, Wei ^b   Wang, Wen ^a   Peng, Jin Song ^d   Zhang, Guo Bin ^a   Zhang, Shaomin ^a   Chen, Xiao Min ^d   Wang, Yan ^a   Li, Ming Hui ^a   Li, Zhenjun ^a   Lu, Shan ^a   Ye, Changyun ^a   De Jong, Menno D ^e   Xu, Jianguo ^a   more..

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c WUHAN UNIVERSITY   (China)

^d Wuhan Centers for Disease Prevention and Control   (China)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHEMOKINE; CYTOKINE; FIBRINOGEN; GAMMA INTERFERON; HEPCIDIN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOLIPASE A; VIRUS DNA; VIRUS RNA;

ADULT; ADVERSE OUTCOME; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLEEDING TIME; BLOOD ANALYSIS; BUNYAVIRUS; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DEATH; DISEASE SEVERITY; FATALITY; FECES CULTURE; FEMALE; HEMORRHAGIC FEVER; HOSPITAL ADMISSION; HUAIYANGSHAN VIRUS; HUMAN; INNATE IMMUNITY; LABORATORY TEST; MALE; NUCLEOTIDE SEQUENCE; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROAT CULTURE; THROMBIN TIME; URINE CULTURE; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

ADULT; AGED; BLOOD; BUNYAVIRIDAE INFECTIONS; CHINA; FECES; FEMALE; HEMORRHAGIC FEVERS, VIRAL; HUMANS; MALE; MIDDLE AGED; ORTHOBUNYAVIRUS; PHARYNX; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, VIRAL; SURVIVAL ANALYSIS; URINE; VIRAL LOAD;

EID: 84863011783     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir804     Document Type: Article

References (17)

1. Zhang YZ, Zhou DJ, Xiong Y, et al. Hemorrhagic fever caused by a novel tick-borne Bunyavirus in Huaiyangshan, China. Zhonghua Liu Xing Bing Xue Za Zhi 2011; 32:209-20.
2. YuXJ, LiangMF, Zhang SY, et al. Fever with thrombocytopenia associated with a novel Bunyavirus in China. N Engl J Med 2011; 364:1523-32.
3. Ito M, Ishikawa Y, Kiguchi H, et al. Distribution of type V secretory phospholipase A2 expression in human hepatocytes damaged by liver disease. J Gastroenterol Hepatol 2004; 19:1140-9. (Pubitemid 39371256)
4. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis 2006; 193:941-4.
5. Onguru P, Dagdas S, Bodur H, et al. Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality. J Clin Lab Anal 2010; 24:163-6.
6. Tennent GA, Brennan SO, Stangou AJ, O'Grady J, Hawkins PN, Pepys MB. Human plasma fibrinogen is synthesized in the liver. Blood 2007; 109:1971-4. (Pubitemid 46348194)
7. Verkerk MS, Visseren FL, Paul Bouter K, Diepersloot RJ. Acutephase response of human hepatocytes after infection with Chlamydia pneumoniae and cytomegalovirus. Eur J Clin Invest 2003; 33:720-5. (Pubitemid 36918636)
8. Jaroszewicz J, Rogalska M, Flisiak R. Serum prohepcidin reflects the degree of liver function impairment in liver cirrhosis. Biomarkers 2008; 13:478-85. (Pubitemid 352044259)
9. De Domenico I, Zhang TY, Koening CL, et al. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest 2010; 120:2395-405.
10. Papa A, Dalla V, Papadimitriou E, Kartalis GN, Antoniadis A. Emergence of Crimean-Congo haemorrhagic fever in Greece. Clin Microbiol Infect 2010; 16:843-7.
11. Hutchinson KL, Rollin PE. Cytokine and chemokine expression in humans infected with Sudan Ebola virus. J Infect Dis 2007; 196(Suppl 2): S357-63. (Pubitemid 351417282)
12. Villinger F, Rollin PE, Brar SS, et al. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis 1999; 179(Suppl 1):S188-91. (Pubitemid 29091401)
13. Feldmann H, Jones S, Klenk HD, Schnittler HJ. Ebola virus: from discovery to vaccine. Nat Rev Immunol 2003; 3:677-85. (Pubitemid 37328670)
14. Saksida A, Duh D, Wraber B, Dedushaj I, Ahmeti S, Avsic-Zupanc T. Interacting roles of immune mechanisms and viral load in the pathogenesis of Crimean-Congo hemorrhagic fever. Clin Vaccine Immunol 2010; 17:1086-93.
15. Chakravarti A, Kumaria R. Circulating levels of tumour necrosis factor-alpha & interferon-gamma in patients with Dengue & Dengue haemorrhagic fever during an outbreak. Indian JMed Res 2006; 123: 25-30.
16. Wauquier N, Becquart P, Padilla C, Baize S, Leroy EM. Human fatal Zaire Ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis 2010; 4:e837.
17. Baize S, Leroy EM, Georges AJ, et al. Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol 2002; 128:163-8. (Pubitemid 34451194)